EICHOR
● Completed
Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children
Condition: SARS-CoV-2 Infection, COVID-19 · Sponsor: BioNTech SE
About this study
This is a Phase 1/2/3 study in healthy children. Dependent upon safety and/or immunogenicity data generated during the course of this study, and the resulting assessment of benefit-risk, the safety, tolerability, and immunogenicity of BNT162b2 in participants \<6 months of age may subsequently be evaluated.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (128)
| University of Alabama at Birmingham - School of Medicine | Birmingham, Alabama, United States | — |
| Phoenix Children's Hospital | Phoenix, Arizona, United States | — |
| SCPMG/Kaiser Permanente Los Angeles Medical Center | Los Angeles, California, United States | — |
| Matrix Clinical Research | Los Angeles, California, United States | — |
| Madera Family Medical Group | Madera, California, United States | — |
| Kaiser Permanente Oakland | Oakland, California, United States | — |
| Clinical & Translational Research Unit (CTRU) & Spectrum BioBank, Stanford University | Palo Alto, California, United States | — |
| Lucile Packard Children's Hospital Stanford | Palo Alto, California, United States | — |
| Center for Clinical Trials, LLC | Paramount, California, United States | — |
| Center for Clinical Trials | Paramount, California, United States | — |
| Peninsula Research Associates | Rolling Hills Estates, California, United States | — |
| Kaiser Permanente Sacramento | Sacramento, California, United States | — |
+ 116 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04816643